Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation
- PMID: 18664535
- PMCID: PMC2579638
- DOI: 10.1210/jc.2008-0396
Increased interleukin (IL)-1beta messenger ribonucleic acid expression in beta -cells of individuals with type 2 diabetes and regulation of IL-1beta in human islets by glucose and autostimulation
Abstract
Context: Elevated glucose levels impair islet function and survival, and it has been proposed that intraislet expression of IL-1beta contributes to glucotoxicity.
Objective: The objective was to investigate IL-1beta mRNA expression in near-pure beta-cells of patients with type 2 diabetes (T2DM) and study the regulation of IL-1beta by glucose in isolated human islets.
Methods: Laser capture microdissection was performed to isolate beta-cells from pancreas sections of 10 type 2 diabetic donors and nine controls, and IL-1beta mRNA expression was analyzed using gene arrays and PCR. Cultured human islets and fluorescence-activated cell sorter-purified human beta-cells were used to study the regulation of IL-1beta expression by glucose and IL-1beta.
Results: Gene array analysis of RNA from beta-cells of individuals with T2DM revealed increased expression of IL-1beta mRNA. Real-time PCR confirmed increased IL-1beta expression in six of 10 T2DM samples, with minimal or no expression in nine control samples. In cultured human islets, IL-1beta mRNA and protein expression was induced by high glucose and IL-1beta autostimulation and decreased by the IL-1 receptor antagonist IL-1Ra. The glucose response was negatively correlated with basal IL-1beta expression levels. Autostimulation was transient and nuclear factor-kappaB dependent. Glucose-induced IL-1beta was biologically active and stimulated IL-8 release. Low picogram per milliliter concentrations of IL-1beta up-regulated inflammatory factors IL-8 and IL-6.
Conclusion: Evidence that IL-1beta mRNA expression is up-regulated in beta-cells of patients with T2DM is presented, and glucose-promoted IL-1beta autostimulation may be a possible contributor.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2579638/bin/zeg0100860870001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2579638/bin/zeg0100860870002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2579638/bin/zeg0100860870003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2579638/bin/zeg0100860870004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2579638/bin/zeg0100860870005.gif)
Similar articles
-
IL-17 in type II diabetes mellitus (T2DM) immunopathogenesis and complications; molecular approaches.Mol Immunol. 2024 Jul;171:66-76. doi: 10.1016/j.molimm.2024.03.009. Epub 2024 May 24. Mol Immunol. 2024. PMID: 38795686 Review.
-
Targeting IL-12 family cytokines: A potential strategy for type 1 and type 2 diabetes mellitus.Biomed Pharmacother. 2024 Jan;170:115958. doi: 10.1016/j.biopha.2023.115958. Epub 2023 Dec 7. Biomed Pharmacother. 2024. PMID: 38064968 Review.
-
Palmitate induces a pro-inflammatory response in human pancreatic islets that mimics CCL2 expression by beta cells in type 2 diabetes.Diabetologia. 2010 Jul;53(7):1395-405. doi: 10.1007/s00125-010-1707-y. Epub 2010 Apr 6. Diabetologia. 2010. PMID: 20369226
-
Osteopontin protects the islets and beta-cells from interleukin-1 beta-mediated cytotoxicity through negative feedback regulation of nitric oxide.Endocrinology. 2007 Feb;148(2):575-84. doi: 10.1210/en.2006-0970. Epub 2006 Nov 16. Endocrinology. 2007. PMID: 17110428
-
Is there a role for locally produced interleukin-1 in the deleterious effects of high glucose or the type 2 diabetes milieu to human pancreatic islets?Diabetes. 2005 Nov;54(11):3238-44. doi: 10.2337/diabetes.54.11.3238. Diabetes. 2005. PMID: 16249450
Cited by
-
Targeting aging and age-related diseases with vaccines.Nat Aging. 2024 Apr;4(4):464-482. doi: 10.1038/s43587-024-00597-0. Epub 2024 Apr 15. Nat Aging. 2024. PMID: 38622408 Review.
-
Fecal Microbiota Transplantation: A Prospective Treatment for Type 2 Diabetes Mellitus.Diabetes Metab Syndr Obes. 2024 Feb 8;17:647-659. doi: 10.2147/DMSO.S447784. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 38347911 Free PMC article. Review.
-
Intracellular C3 protects β-cells from IL-1β-driven cytotoxicity via interaction with Fyn-related kinase.Proc Natl Acad Sci U S A. 2024 Feb 20;121(8):e2312621121. doi: 10.1073/pnas.2312621121. Epub 2024 Feb 12. Proc Natl Acad Sci U S A. 2024. PMID: 38346191 Free PMC article.
-
How do parasitic worms prevent diabetes? An exploration of their influence on macrophage and β-cell crosstalk.Front Endocrinol (Lausanne). 2023 Jul 26;14:1205219. doi: 10.3389/fendo.2023.1205219. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37564976 Free PMC article. Review.
-
Mechanism of immune attack in the progression of obesity-related type 2 diabetes.World J Diabetes. 2023 May 15;14(5):494-511. doi: 10.4239/wjd.v14.i5.494. World J Diabetes. 2023. PMID: 37273249 Free PMC article. Review.
References
-
- Donath MY, Gross DJ, Cerasi E, Kaiser N 1999 Hyperglycemia-induced β-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48:738–744 - PubMed
-
- Mandrup-Poulsen T 1996 The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 39:1005–1029 - PubMed
-
- Eizirik DL, Mandrup-Poulsen T 2001 A choice of death—the signal-transduction of immune-mediated β-cell apoptosis. Diabetologia 44:2115–2133 - PubMed
-
- Donath MY, Storling J, Maedler K, Mandrup-Poulsen T 2003 Inflammatory mediators and islet β-cell failure: a link between type 1 and type 2 diabetes. J Mol Med 81:455–470 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical